Keyphrases
Protein Electrophoresis
100%
Giant Cell Arteritis
100%
CT Findings
100%
Ventilator-associated Pneumonia
100%
Subglottic Secretion Drainage
100%
COVID-19
100%
Registry Study
100%
Drug Use
100%
Adverse Drug Reaction
100%
Drug Safety
100%
Hospital Registry
100%
Complement Factors
100%
Clinical Laboratory
100%
Compound Heterozygous mutation
100%
Laboratory Standards
100%
Capillary
100%
Positron Emission Tomography-computed Tomography (PET-CT)
100%
Ischemic Events
100%
Vertebral Artery
66%
Ischemic Symptoms
50%
Microorganisms
50%
Meningococcemia
33%
Electropherogram
33%
Routine Control
33%
Oropharyngeal Infection
33%
Underestimated Risk
33%
Classical Pathway Activation
33%
Visual Loss
33%
Ventilator-free Days
33%
Protected Specimen Brush
33%
Nosocomial Pneumonia
33%
Bronchoalveolar Lavage
33%
Mechanically Ventilated Patients
33%
Intensive Care Unit
33%
Recurrent Infection
33%
Invasive Pneumococcal Disease
33%
Frameshift
33%
Common Cause
33%
Clinical Records
33%
Truncated Protein
33%
Working Diagnosis
33%
Homozygous Deletion
33%
Exon 12
33%
Deficiency Diagnosis
33%
Non-alcoholic Fatty Liver Disease (NAFLD)
33%
Young Males
33%
Autoimmunity
33%
European Federation
33%
Complement Deficiency
33%
5′-nucleotides
33%
Medicine and Dentistry
Complement Factor I
100%
Factor I Deficiency
100%
Protein Electrophoresis
100%
Adverse Drug Reaction
100%
Positron Emission Tomography-Computed Tomography
100%
Capillary
100%
COVID-19
100%
Giant-Cell Arteritis
100%
Vertebral Artery
66%
Diseases
59%
Infection
47%
Meningococcemia
33%
Isoetarine
33%
Nucleotide
33%
Autoimmunity
33%
Exon
33%
Electrophoresis
33%
Gene Sequence
33%
Infancy
33%
Meningococcal Disease
33%
Recurrent Infection
33%
Fibrinogen
33%
Complement Deficiency
33%
Nonalcoholic Fatty Liver
33%
Visual Impairment
33%
Off-Label Use
28%
Physical Examination
16%
Carotid Artery
16%
Aortic Arch
16%
Subclavian Artery
16%
Abdominal Aorta
16%
Axillary Artery
16%
Brachiocephalic Artery
16%
Steroid Therapy
16%
Aortitis
16%
Ascending Aorta
16%
Descending Aorta
16%
Fisher Exact Test
16%
Vasculitis
16%
Lopinavir/Ritonavir
14%
Clinical Trial
14%
Sequela
14%
Azithromycin
14%
Patient Registry
14%
Hydroxychloroquine
14%
Fatality
14%
Drug Therapy
14%
